Appendix: Coding
Breast Cancer Screening
3014F Screening mammography results documented and reviewed
Colorectal Cancer Screening
3017F Colorectal cancer screening results documented and reviewed
G0328 FOBT
Note: Z12.11 is the diagnosis code for screening for malignant neoplasm of the colon.
Annual Flu Vaccines
90630 Influenza split virus vaccine, quadrivalent, preservative free, for intradermal use
90653 Influenza virus vaccine, inactivated, subunit, adjuvanted, for intramuscular use
90654 Influenza virus vaccine, split virus, preservative-free, for intradermal use
90656 Influenza virus vaccine, trivalent, split virus, preservative free, when administered to individuals three years and older, for intramuscular use
90660 Influenza virus vaccine, live, for intranasal use
90661 Influenza virus vaccine, derived from cell cultures, subunit, preservative and antibiotic free, for intramuscular use
90662 Influenza virus vaccine, split virus, preservative free, enhanced immunogenicity via increased antigen content, for intramuscular use
90672 Influenza virus vaccine, quadrivalent, live, for intranasal use
90673 Influenza virus vaccine, trivalent, derived from recombinant DNA (RIV3), hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use
90686 Influenza virus vaccine, quadrivalent, split virus, preservative free, when administered to individuals three years of age and older, for intramuscular use
90688 Influenza virus vaccine, quadrivalent, split virus, when administered to individuals three years of age and older, for intramuscular use
Q2035 Influenza virus vaccine, split virus, when administered to individuals three years of age and older, for intramuscular use (Afluria®)
Q2036 Influenza virus vaccine, split virus, when administered to individuals three years of age and older, for intramuscular use (Flulaval®)
Q2037 Influenza virus vaccine, split virus, when administered to individuals three years of age and older, for intramuscular use (Fluvirin®)
Q2038 Influenza virus vaccine, split virus, when administered to individuals three years of age and older, for intramuscular use (Fluzone®)
Q2039 Influenza virus vaccine, when administered to individuals three years of age and older, intramuscular use (not otherwise specified)
Annual Flu Vaccines - Administration
G0008 Seasonal Influenza Virus Vaccine Administration G8482 Influenza immunization administered or previously received
G8483 Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons)
G8484 Influenza immunization was not administered, reason not given
Improving or Maintaining Physical Health
1170F Functional status assessed
Improving or Maintaining Mental Health
G8431 Screening for depression is documented as being positive and a follow-up plan is documented
3351F Negative screen for depressive symptoms as categorized by using a standardized depression screening/assessment tool (MDD)
3352F No significant depressive symptoms as categorized by using a standardized depression assessment tool (MDD)
3353F Mild to moderate depressive symptoms as categorized by using a standardized depression screening/ assessment tool (MDD)
3354F Clinically significant depressive symptoms as categorized by using a standardized depression screening/assessment tool (MDD)
3725F Screening for depression performed G0444 Annual depression screening, 15 minutes
G8510 Screening for depression is documented as negative, a follow-up plan is not required
G9212 DSM-IVTM criteria for major depressive disorder documented at the initial evaluation
G9393 Patient with an initial PHQ-9 score greater than nine who achieves remission at 12 months as demonstrated by a 12-month (+/- 30 days) PHQ-9 score of less than five
G9395 Patient with an initial PHQ-9 score greater than nine who did not achieve remission at 12 months as demonstrated by a 12-month (+/- 30 days) PHQ-9 score greater than or equal to five
G9396 Patient with an initial PHQ-9 score greater than nine who was not assessed for remission at 12 months (+/- 30 days)
Adult BMI Assessment
G8417 BMI is documented above normal parameters and a follow-up plan is documented
G8418 BMI is documented below normal parameters and a follow-up plan is documented
G8419 BMI documented outside normal parameters, no follow-up plan documented, no reason given
G8420 BMI is documented within normal parameters and no follow-up plan is required
G8421 BMI not documented and no reason is given
G8422 BMI not documented, documentation the patient is not eligible for BMI calculation
COA – Medication Review
G8427 Eligible clinician attests to documenting in the medical record they obtained, updated or reviewed patients’ current medications
1159F Medication list documented in medical record
1160F Review of all meds by prescriber or clinical pharmacists documented in medical record
G8428 Current list of medications not documented as obtained, updated or reviewed by the eligible clinician, reason not given
G8430 Eligible clinician attests to documenting in the medical record the patient is not eligible for a current list of medications being obtained, updated or reviewed by the eligible clinician
Medication Adherence Tips
1159F Medication list documented in medical record
1160F Medication list documented in medical record
COA - Functional Status Assessment
1170F Functional status assessed
COA – Pain Assessment
G8442 Pain assessment not documented as being performed, documentation patients are not eligible for a pain assessment using a standardized tool
1125F Pain severity quantified; pain present
1126F Pain severity quantified; no pain present
Improving Bladder Control
0509F Urinary incontinence plan of care documented or
0509F-8P Urinary incontinence plan of care not implemented, no reason given
Diabetes Care – Eye Exam
2022F Dilated eye exam with interpretation
2024F Seven standard field stereoscopic photos with interpretation
2026F Eye imaging validated to match diagnosis from seven standard field stereoscopic photos results documented and reviewed
3072F Low risk for retinopathy (no evidence of retinopathy in the prior year)
Hypertension – Controlling Blood Pressure
G8473 Angiotensin converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) therapy prescribed
G8474 Angiotensin converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) therapy not prescribed for reasons documented by the clinician (e.g., allergy, intolerance, pregnancy, renal failure due to ACE inhibitor, diseases of the aortic or mitral valve, other medical reasons, patient declined, other patient reasons, lack of drug availability, other reasons attributable to the healthcare system)
G8475 Angiotensin converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) therapy not prescribed, reason not given
G8476 Most recent blood pressure has a systolic measurement of < 140mm Hg and a diastolic measurement of < 90mm Hg
G8477 Most recent blood pressure has a systolic measurement of >=140mm Hg and/or a diastolic measurement of >=90mm Hg section
G8478 Blood pressure measurement not performed or documented, reason not given